Halozyme Therapeutics Inc. buy Wells Fargo & Company
Start price
07.06.24
/
50%
€47.16
Target price
07.06.25
€53.56
Performance (%)
0.95%
End price
08.06.25
€47.61
Summary
This prediction ended on 08.06.25 with a price of €47.61. The BUY prediction by Wells_Fargo___Compan for Halozyme Therapeutics Inc. closed nearly unchanged. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Halozyme Therapeutics Inc. | -4.658% | -4.658% | 9.584% |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Wells Fargo & Company from $48.00 to $58.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
In the thread Trading Halozyme Therapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten